| In millions, except per share items | Jun-30-22 | Jun-05-22 | Jun-30-21 | Jun-05-21 | Jun-30-20 |
| | 10-K | 8-K | 10-K | 8-K | 10-K |
| Revenues: |
| Investment Management | | | | | 3.3 |
| General Corporate | | | | | 0.2 |
| Durable Medical Equipment | | | | | 55.7 |
| Total revenues [+] | -8.2 | 68.0 | 0.0 | 60.9 | 59.0 |
| Lease / rental | | | | | 21.4 |
| Revenue growth | | 11.7% | -100.0% | | |
| Cost of goods sold | -72.1 | 63.8 | 0.0 | 56.3 | 25.9 |
| Gross profit | 63.9 | 4.1 | 0.0 | 4.5 | 33.1 |
| Gross margin | -779.7% | 6.1% | | 7.5% | 56.1% |
| Selling, general and administrative | | 6.0 | | 5.9 | 6.5 |
| Other operating expenses | 76.9 | | | | 27.4 |
| EBITDA [+] | -4.2 | -1.8 | | -1.4 | 7.5 |
| EBITDA growth | | 36.3% | -100.0% | | |
| EBITDA margin | 51.5% | -2.7% | | -2.2% | 12.7% |
| Depreciation | 7.1 | 2.3 | -1.7 | 2.4 | 8.9 |
| EBITA | -11.3 | -4.1 | 1.7 | -3.7 | -1.4 |
| EBITA margin | 138.0% | -6.0% | | -6.1% | -2.4% |
| Amortization of intangibles | 1.7 | | 1.7 | | 1.9 |
| EBIT [+] | -13.0 | -4.1 | 0.0 | -3.7 | -3.3 |
| EBIT growth | | 9.9% | -100.0% | | |
| EBIT margin | 158.7% | -6.0% | | -6.1% | -5.6% |
| Non-recurring items | -0.1 | | | | -1.1 |
| Interest expense | | 5.8 | | 4.9 | 4.6 |
| Interest expense | 5.8 | 5.8 | 5.6 | 4.9 | 4.6 |
| Other income (expense), net [+] | 3.7 | -5.1 | -1.9 | 1.8 | -6.6 |
| Gain (loss) on debt retirement | | -0.2 | | -1.9 | |
| Other | -2.1 | 0.0 | -1.6 | 0.0 | 0.0 |
| Pre-tax income | -15.0 | -15.0 | -7.5 | -6.8 | -13.3 |
| Income taxes | 0.0 | 0.0 | 1.8 | 1.7 | 0.0 |
| Earnings from continuing ops | -14.9 | -14.9 | -8.1 | -7.9 | -26.7 |
| Earnings from discontinued ops | | | | 0.6 | 0.2 |
| Net income | -14.9 | -14.9 | -8.1 | -7.3 | -26.5 |
| Net margin | 181.8% | -21.9% | | -12.0% | -44.9% |
| |
| Basic EPS [+] | ($0.56) | ($0.56) | ($0.31) | ($0.31) | ($1.05) |
| Growth | 79.4% | 80.5% | -70.5% | | |
| Diluted EPS [+] | ($0.56) | ($0.56) | ($0.31) | ($0.31) | ($1.05) |
| Growth | 79.4% | 80.5% | -70.5% | | |
| |
| Shares outstanding (basic) [+] | 26.8 | 26.8 | 26.1 | 25.7 | 25.4 |
| Growth | 2.7% | 4.1% | 2.6% | | |
| Shares outstanding (diluted) [+] | 26.8 | 26.8 | 26.1 | 25.7 | 25.4 |
| Growth | 2.7% | 4.1% | 2.6% | | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |